Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 965 of 6351
-
Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
Disease control Stopped earlyThis is an open-label, multi-center, phase I study designed to assess the maximum tolerated dose of ribociclib and belinostat in combination. The trial will open with a dose escalation followed by an expansion cohort at the identified dose. Dose escalation will be open to the enr…
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Tailored CF drug trials offer hope for patients with rare mutations
Disease control Recruiting nowThe purpose of this study is to validate and utilize a personalized medicine approach to identify potential treatments with current FDA approved CFTR modifiers for non-approved CF gene mutations. The study will perform ex vivo testing of CFTR function and current marketed CFTR mo…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail shows promise for tough bladder cancer
Disease control OngoingThe purpose of this study is to see how well the study drugs called Ipilimumab plus Nivolumab (IPI-NIVO) work when added to another study drug called Sacituzumab Govitecan for people who have metastatic bladder cancer.
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for rare cancers: targeted pill shrinks tumors in early trial
Disease control Recruiting nowThis phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic). Larotrectinib may stop the growth of tumo…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Personalized dosing may boost immune recovery in stem cell transplants
Disease control OngoingThe purpose of this study is to see if conditioning regimens that include personalized rabbit ATG (P-rATG) help the immune system recover sooner and decrease the chances of transplant-related side effects. Participants in this study will be children and adults who have acute leuk…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for Hard-to-Treat colorectal cancer: liquid biopsy guides smarter drug choice
Disease control OngoingThis study is a prospective, randomized phase III, to evaluate if in patients with mCRC RAS/BRAF wild type on tumor tissue and RAS mutations on liquid biopsy, treating in first line with antibody anti-VEGF (bevacizumab) plus chemotherapy (FOLFIRI) is superior in terms of PFS comp…
Phase 3 • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Balloon that delivers medicine directly to heart arteries could offer Stent-Free option
Disease control OngoingThe aim of the study is to assess continued safety and efficacy of the SeQuent® SCB. The product under investigation will be used in routine clinical practice according to the latest European Society of Cardiology (ESC) guidelines and according to the Instructions for Use (IFU). …
Sponsor: B. Braun Melsungen AG • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New targeted therapy combo aims to boost remission in Tough-to-Treat lymphoma
Disease control CompletedAn open-label, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) with rituximab, ifosfamide, carboplatin and etoposide (R-ICE) alone as salvage therapy in patients with primary refractory or rela…
Phase 3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Weekly insulin shot could replace daily injections for type 1 diabetes
Disease control CompletedThis study compares insulin icodec (a new insulin) to insulin degludec (an insulin already available on the market) in people with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin degludec taken daily. Partici…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a tiny implant fix a leaky heart valve without open surgery?
Disease control CancelledAn early feasibility study to evaluate the safety and feasibility of the PLAR Implant and Delivery System to treat severe functional mitral regurgitation and to gather preliminary data on its performance thereby providing guidance for future clinical development. The study is a s…
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
A tiny implant might fix a leaky heart valve without cutting open the chest
Disease control CancelledAn early feasibility study to evaluate the safety and feasibility of the PLAR Implant and Delivery System to treat severe degenerative mitral regurgitation and to gather preliminary data on its performance thereby providing guidance for future clinical development. The study is a…
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a lower steroid dose preserve strength in young boys with DMD?
Disease control Recruiting nowThe hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose.
Phase 4 • Sponsor: Anne M. Connolly • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can an oral drug stop COVID-19 pneumonia from turning deadly?
Disease control CancelledA trial of EC-18 in patients with mild/moderate pneumonia due to COVID-19
Phase 2 • Sponsor: Enzychem Lifesciences Corporation • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A smarter brace for scoliosis: does 3D design stop curves from worsening?
Disease control Recruiting nowIdiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brac…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
At-Home cancer test could save lives in alaska native communities
Diagnosis CompletedOnly 59% of Alaska Native people have been adequately screened for colorectal cancer (CRC) despite having the highest reported incidence of CRC in the world. A new at-home multi-target stool DNA screening test (MT-sDNA; Cologuard®) with high sensitivity for pre-cancerous polyps a…
Sponsor: Alaska Native Tribal Health Consortium • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can a phone app tame sickle cell pain and cut opioid use?
Symptom relief CompletedOur long-term goal is to reduce stress and improve sickle cell disease (SCD) pain control with less opioid use through an intervention with self-management relaxation/distraction exercises (RDE), named You Cope, We Support (YCWS). Americans living with SCD suffer recurrent episod…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare nerve cancer: drug combo targets genetic flaw
Disease control Recruiting nowThe purpose of this study is to see whether the study drug ASTX727 is an effective treatment for people who have MPNST with a PCR2 mutation. ASTX727 is a combination of two drugs (cedazuridine and decitabine) that have been designed to target cancer cells with a PCR2 mutation an…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can sound waves reveal pancreatic cancer without a biopsy?
Diagnosis CompletedTo assess the diagnostic accuracy of Shear Wave elastography (SWE) for the diagnosis of pancreatic adenocarcinoma.
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Reading Cancer's genetic playbook: a quest to match patients to the right experimental therapy
Knowledge-focused Recruiting nowThe goal of this observational study is to attempt to find altered genetic 'switches' (mutations) in adults with advanced solid cancers who are being considered for, or are participating in, early-phase cancer clinical trials. Research has shown that cancer cells make use of key …
Sponsor: Institute of Cancer Research, United Kingdom • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Old diabetes drug, new hope: could metformin stop myeloma before it starts?
Prevention OngoingThe purpose of this research is to understand whether the drug metformin could be used in the future to help prevent patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) from developing multiple myeloma. The names of the s…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC